Stay updated with breaking news from Fully Human. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn's Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody ... | March 25, 2022
T-Charge, a next-generation platform that aims to revolutionize CAR-T cell therapy, will serve as foundation for various investigational CAR-T therapies Early data from first-in-human dose-escalation
/PRNewswire/ -- Novartis today announced the introduction of T-Charge™, the company's next-generation CAR-T platform that will serve as the foundation for...
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021
Focused medicines company delivering strong operational performanceBuilding depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint Confident to grow